Neural Biomarkers of Electroconvulsive Therapy Response — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neural Biomarkers of Electroconvulsive Therapy Response — Stella

Home/Electroconvulsive Therapy Treated Patients/

View on ClinicalTrials.gov

Recruiting

Back to Electroconvulsive Therapy Treated Patients trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

The Zucker Hillside Hospital, Glen Oaks, New York

Key details

Sponsor

Northwell Health

Collaborators

National Institutes of Health (NIH)

Enrollment target

~75 participants

Started

April 2020

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.